Piper Sandler logo

Piper Sandler

0 followers

PIPR

Performance

About Piper Sandler

Piper Sandler is an American multinational investment bank and financial services firm focused on mergers and acquisitions, financial restructuring, public offerings, public finance, institutional brokerage, investment management, and securities research. The firm operates across advisory, underwriting, and research services, serving corporate clients, financial sponsors, and institutional investors with a global footprint. Founded in 1895, Piper Sandler positions itself as a leading advisor in U.S. M&A and capital markets, connecting capital with opportunity. The company highlights its heritage and broad sector coverage, including healthcare, financial services, real estate, and technology.

Recent News

Blockchain-Based Lender Figure Named 2026 'Top Pick' By Wall Street Analyst

Nike Gets Another Downgrade. HSBC Says Turnaround Strategy Is Now a 'Show Me' Story

Amazon's Record Q1 Beats Forecasts, AWS Drives Analyst Target Hikes

Tesla Optimus Is Already Benefiting Investors, Top Wall Street Firm Says

Here Is Why Weatherford (WFRD) Is Among the 7 Best Geothermal Stocks to Buy Now

Options Traders Pick Up Pharma Stock After Eli Lilly Buyout

Better Credit Quality Lets M&T Lean Into Buybacks

Amazon AWS Posts 28% YoY Growth, JPMorgan Lifts Price Target to $330

Stock Movers: Soleno, Tyson, Applied Opto (Podcast)

10 Best Low-Risk Investments in May 2026

5 Stocks Big Short’s Michael Burry Is Betting On

3 Dividend Stocks Defying the Market Downturn Amid the Iran Conflict

Iran’s Military May Be Decimated, but It’s Winning the Energy War as It Controls Who Gets Cargoes Through the Strait of Hormuz

SEC's Reporting Rule Change Could Have REITs Balancing Transparency With Convenience

M&T Takes ‘Patient’ Approach to M&A, CFO Says

Nike Shares Are Still Not Cheap After 30% Drawdown This Year, Says Piper Sandler

Improved Credit Quality at M&T Helps Push Earnings Higher

Barclays Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $25.00

Gainplan LLC Purchases New Position in Amazon.com, Inc. $AMZN

Why One Analyst Believes Microsoft’s Stock May Be Bottoming Out

Park Capital's Latest RMBS Raises $380.8 Million

Software Stock Dogs Have Joined Market Rally. There's a Classic Investing Lesson in the Rebound

Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now

L.A. Bank to Buy U.S. Commercial Banking Unit From Japan's SMBC

Bill Ackman Wants a Little Berkshire of His Own. Piper Sandler Says There's a 'Secret Sauce'

US Futures Near Record as Iran Peace Hopes and Earnings Drive Large‑Cap Stocks

Fairmount Funds Sells Cogent Biosciences (COGT) Shares for $242.6m

Is Akamai (AKAM) the Best Edge Computing Stock to Buy Right Now?

Wolfe Research Lowers Tractor Supply Stock Price Target on Guide Concerns

10 Best Oil Stocks to Buy Right Now

Wall Street Doesn’t Understand the CDN Business, What AI Agentic Traffic Is, and How Bits Are Delivered

BioAge Labs Provides Business Updates

BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline

Munis Outperform UST Selloff Amid U.S.-Iran War

Dara Capital US Inc. Purchases New Position in Adobe Inc. $ADBE

Piper Sandler Sees “Two Halves” In Mortgage Market, Lowers Rithm Capital (RITM)

Can Amika Conquer Body Care?

NIKE (NKE) Downgraded to Neutral, Price Target Cut by $10

The IPO Buzz: HMH Holding (HMH) Prices IPO at $20 – Below Mid-Point

This Biotech Firm Has Room to Run, Even as Its Drug Royalties Are Set to Shrink

The IPO Buzz: Generate Biomedicines (GENB Proposed) Launches $400 Million IPO

Simmons Bank Hires New Leaders to Boost Organic Growth

The After-School Special

UBS Maintains Buy Rating on Deckers Outdoor (DECK)

Office Loan Woes Bite a Pair of Banks

Zacks Research Estimates Glaukos FY2028 Earnings

Eastern Swears Off M&A Amid Activist Investor's Pressure

Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $2.00

Virtu Financial (VIRT) Eyes a “Big Quarter” – Record Volumes Ahead?

Figure Stock Jumps as Druckenmiller Invests $77M, Analysts Raise Price Targets